SPACs: Criteria for Successful Launches

2:00 PM - 3:00 PM (EST), Tuesday, February 16, 2021
Biotech SPACs (special purpose acquisition companies) have reached record levels in 2020. A recent Forbes article shows this boom referencing nearly two dozen new SPACS through the third quarter. As companies consider options for accessing capital and investors seek new opportunities, attend this session to hear about the benefits and risks of this vehicle. Legal, investor, and executive voices will provide insight on this emerging trend for the industry and insight on the future.
Moderator
photo
Managing Director, Capital Markets Advisory
Westwicke, an ICR Company
Speakers
photo
Managing Director, Capital Markets Advisory
Westwicke, an ICR Company
photo
President
CHARDAN
photo
Vincerx
CEO and Chairman of the board of directors
photo
Chief Executive Officer
Blue Water Vaccines
photo
Director, Capital Markets & Financial Services Policy
Biotechnology Innovation Organization
photo
Partner
Fenwick & West, LLP